Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT01170260 |
| Other study ID # |
NIAAA RO1 AA013844-05 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
August 2010 |
| Est. completion date |
June 2014 |
Study information
| Verified date |
April 2024 |
| Source |
University of New Mexico |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
This research is studying behaviors that young people engage in that may place them at risk
for contracting a sexually transmitted disease like HIV/AIDS, and what kind of educational
program works best to reduce these risky behaviors.
Description:
During baseline assessment, a computer questionnaire is administered, including questions
about participants' attitudes, beliefs, and behaviors regarding sexual behavior, condom use,
and drug use. A saliva sample is provided as well. A "Time-Line Follow-Back" is conducted,
noting on which days certain activities occurred, such as sexual intercourse, alcohol use,
marijuana use, and cigarette use. A urine sample is also collected in order to test for the
STD's chlamydia and gonorrhea (if results are positive, we schedule a meeting with the
participant to administer medication to treat the STD).
In the second session, a 3-hour interventional health class is held with groups of
same-gender participants. There are 3 different health classes (one focusing just on sex risk
reduction, one focusing on sex and alcohol risk reduction, and one focusing on sex, alcohol,
and marijuana risk reduction); participants are randomly assigned to one.
Participants are contacted 3 months after the intervention, 6 months after, 9 months after,
and 12 months after, in order to meet. These meetings entail completing another Time-Line
Follow-Back and completing another questionnaire. At the final 12 month meeting, we collect
another urine sample to again test for chlamydia and gonorrhea. As before, if results are
positive, we schedule a meeting with the participant to administer medical treatment.
